choline has been researched along with Bladder Cancer in 16 studies
Excerpt | Relevance | Reference |
---|---|---|
"The presence of residual bladder cancer (pTa-pT4) was correctly detected in 21 of 25 histologically tumor-positive patients (84%) by CT and in 24 of 25 patients (96%) by (11)C-choline PET." | 9.12 | Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. ( Beer, AJ; Bössner, P; Hartung, R; Metz, S; Paul, R; Picchio, M; Piert, M; Schwaiger, M; Souvatzoglou, M; Treiber, U; van Randenborgh, H; Weirich, G, 2006) |
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis." | 8.98 | Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018) |
"Choline metabolism alteration is considered as a metabolic hallmark in cancer, reflecting the complex interactions between carcinogenic signaling pathways and cancer metabolism, but little is known about whether genetic variants in the metabolism pathway contribute to the susceptibility of bladder cancer." | 8.12 | Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population. ( Chu, H; Du, M; Gu, J; Han, Z; Liu, H; Liu, Y; Wu, Y; Xin, J; Zhang, Z, 2022) |
"The aim of this study was to evaluate of C-choline PET/CT in bladder cancer (BC) patients with suspected relapse after primary therapy." | 7.81 | 11C-choline PET/CT for restaging of bladder cancer. ( Bianchi, L; Castellucci, P; Ceci, F; Chichero, J; Chondrogiannis, S; Colletti, PM; Costa, S; Fanti, S; Graziani, T; Lopes, FL; Rubello, D; Schiavina, R, 2015) |
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard." | 7.81 | 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015) |
"In patients with bladder cancer (BCa) preoperative staging with (11)C-choline positron emission tomography-computed tomography (PET/CT) could be used to derive prognostic information and hence stratify patients preoperatively with respect to disease management." | 7.80 | Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. ( Beer, AJ; Eiber, M; Gschwend, JE; Haller, B; Heck, MM; Horn, T; Krause, BJ; Maurer, T; Schwaiger, M; Souvatzoglou, M; Treiber, U, 2014) |
"In seven patients, no residual tumour was found after surgery." | 6.70 | Visualisation of bladder cancer using (11)C-choline PET: first clinical experience. ( de Jong, IJ; Elsinga, PH; Jongen, MM; Mensink, HJ; Pruim, J; Vaalburg, W, 2002) |
"The presence of residual bladder cancer (pTa-pT4) was correctly detected in 21 of 25 histologically tumor-positive patients (84%) by CT and in 24 of 25 patients (96%) by (11)C-choline PET." | 5.12 | Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. ( Beer, AJ; Bössner, P; Hartung, R; Metz, S; Paul, R; Picchio, M; Piert, M; Schwaiger, M; Souvatzoglou, M; Treiber, U; van Randenborgh, H; Weirich, G, 2006) |
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis." | 4.98 | Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018) |
"Choline metabolism alteration is considered as a metabolic hallmark in cancer, reflecting the complex interactions between carcinogenic signaling pathways and cancer metabolism, but little is known about whether genetic variants in the metabolism pathway contribute to the susceptibility of bladder cancer." | 4.12 | Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population. ( Chu, H; Du, M; Gu, J; Han, Z; Liu, H; Liu, Y; Wu, Y; Xin, J; Zhang, Z, 2022) |
"The aim of this study was to evaluate of C-choline PET/CT in bladder cancer (BC) patients with suspected relapse after primary therapy." | 3.81 | 11C-choline PET/CT for restaging of bladder cancer. ( Bianchi, L; Castellucci, P; Ceci, F; Chichero, J; Chondrogiannis, S; Colletti, PM; Costa, S; Fanti, S; Graziani, T; Lopes, FL; Rubello, D; Schiavina, R, 2015) |
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard." | 3.81 | 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015) |
"In patients with bladder cancer (BCa) preoperative staging with (11)C-choline positron emission tomography-computed tomography (PET/CT) could be used to derive prognostic information and hence stratify patients preoperatively with respect to disease management." | 3.80 | Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. ( Beer, AJ; Eiber, M; Gschwend, JE; Haller, B; Heck, MM; Horn, T; Krause, BJ; Maurer, T; Schwaiger, M; Souvatzoglou, M; Treiber, U, 2014) |
"The study group included 20 consecutive patients with bladder cancer who underwent evaluation for local and metastatic disease using 11C-choline and 18F-FDG positron emission tomography/computerized tomography." | 3.77 | Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. ( Baniel, J; Golan, S; Groshar, D; Sopov, V, 2011) |
"In seven patients, no residual tumour was found after surgery." | 2.70 | Visualisation of bladder cancer using (11)C-choline PET: first clinical experience. ( de Jong, IJ; Elsinga, PH; Jongen, MM; Mensink, HJ; Pruim, J; Vaalburg, W, 2002) |
"With the high risk of recurrence for bladder cancer following the initial diagnoses, lifelong monitoring of patients is necessary." | 1.38 | NMR-based metabolomics study of canine bladder cancer. ( Bonney, P; Knapp, DW; Liu, L; Nagana Gowda, GA; Raftery, D; Stewart, J; Wei, S; Zhang, J, 2012) |
"11C-choline uptake was found in all primary transitional cell carcinomas, with a maximum standardized uptake value of 7." | 1.33 | Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. ( Chisin, R; Freedman, N; Gofrit, ON; Katz, R; Klein, M; Libson, E; Mishani, E; Orevi, M; Pode, D; Shapiro, A, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Han, Z | 1 |
Gu, J | 1 |
Xin, J | 1 |
Liu, H | 1 |
Wu, Y | 1 |
Du, M | 1 |
Chu, H | 1 |
Liu, Y | 1 |
Zhang, Z | 1 |
Parekh, A | 1 |
Hagan, I | 1 |
Capaldi, L | 1 |
Lyburn, I | 1 |
Kim, SJ | 1 |
Koo, PJ | 1 |
Pak, K | 1 |
Kim, IJ | 1 |
Kim, K | 1 |
Brunocilla, E | 1 |
Ceci, F | 3 |
Schiavina, R | 3 |
Castellucci, P | 3 |
Maffione, AM | 1 |
Cevenini, M | 1 |
Bianchi, L | 3 |
Borghesi, M | 1 |
Giunchi, F | 1 |
Fiorentino, M | 1 |
Chondrogiannis, S | 2 |
Colletti, PM | 3 |
Rubello, D | 3 |
Fanti, S | 3 |
Martorana, G | 2 |
Maurer, T | 2 |
Horn, T | 1 |
Souvatzoglou, M | 3 |
Eiber, M | 1 |
Beer, AJ | 2 |
Heck, MM | 1 |
Haller, B | 2 |
Gschwend, JE | 2 |
Schwaiger, M | 3 |
Treiber, U | 3 |
Krause, BJ | 2 |
Graziani, T | 2 |
Lopes, FL | 1 |
Chichero, J | 1 |
Costa, S | 1 |
Pultrone, C | 1 |
Eugenio, B | 1 |
Kanda, T | 1 |
Nakagomi, K | 2 |
Goto, S | 2 |
Torizuka, T | 2 |
Golan, S | 1 |
Sopov, V | 1 |
Baniel, J | 1 |
Groshar, D | 1 |
Kübler, H | 1 |
Opercan, K | 1 |
Schmidt, S | 1 |
Herrmann, K | 1 |
Stollfuss, J | 1 |
Weirich, G | 2 |
Orevi, M | 2 |
Klein, M | 2 |
Mishani, E | 2 |
Chisin, R | 2 |
Freedman, N | 2 |
Gofrit, ON | 2 |
Zhang, J | 1 |
Wei, S | 1 |
Liu, L | 1 |
Nagana Gowda, GA | 1 |
Bonney, P | 1 |
Stewart, J | 1 |
Knapp, DW | 1 |
Raftery, D | 1 |
de Jong, IJ | 1 |
Pruim, J | 1 |
Elsinga, PH | 1 |
Jongen, MM | 1 |
Mensink, HJ | 1 |
Vaalburg, W | 1 |
Picchio, M | 1 |
Metz, S | 1 |
Bössner, P | 1 |
van Randenborgh, H | 1 |
Paul, R | 1 |
Hartung, R | 1 |
Piert, M | 1 |
Yoshida, S | 1 |
Futatsubashi, M | 1 |
Pode, D | 1 |
Shapiro, A | 1 |
Katz, R | 1 |
Libson, E | 1 |
1 review available for choline and Bladder Cancer
Article | Year |
---|---|
Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.
Topics: Acetates; Carbon; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Humans; Likelihood Fu | 2018 |
2 trials available for choline and Bladder Cancer
Article | Year |
---|---|
Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Chol | 2002 |
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
Topics: Aged; Aged, 80 and over; Choline; Contrast Media; Female; Humans; Male; Middle Aged; Neoplasm Stagin | 2006 |
13 other studies available for choline and Bladder Cancer
Article | Year |
---|---|
Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population.
Topics: Case-Control Studies; China; Choline; Female; Genetic Predisposition to Disease; Humans; Male; Polym | 2022 |
Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
Topics: Aged; Carcinoma, Papillary; Choline; Humans; Incidental Findings; Male; Positron Emission Tomography | 2017 |
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Female; Humans; Lymph Nodes; Male; Middle Ag | 2014 |
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.
Topics: Carbon Radioisotopes; Choline; Cystectomy; Humans; Kaplan-Meier Estimate; Multimodal Imaging; Neopla | 2014 |
11C-choline PET/CT for restaging of bladder cancer.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Female; Humans; Male; Middle Aged; Multimoda | 2015 |
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Female; Humans; Lymphatic | 2015 |
[Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer].
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron | 2008 |
Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Transitional Cell; Ch | 2011 |
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Cystectomy; Female; Humans | 2012 |
11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.
Topics: Acetates; Aged; Aged, 80 and over; Biological Transport; Carbon Radioisotopes; Choline; Female; Huma | 2012 |
NMR-based metabolomics study of canine bladder cancer.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Biomarkers, Tumor; Carcinoma, Transitional Cell; Choline; C | 2012 |
C-choline positron emission tomography in bladder cancer: report of four cases.
Topics: Aged; Bone Neoplasms; Carbon Isotopes; Choline; Female; Humans; Male; Middle Aged; Positron-Emission | 2006 |
Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Disease Progre | 2006 |